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Babesiosis-associated immune thrombocytopenia
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Abstract: Thrombocytopenia is a common feature of babesiosis. The mechanism for thrombocytopenia in
babesiosis remains elusive. We report a case of babesiosis with severe new onset immune thrombocytopenia
(ITP). In addition to antibiotics treatment for babesiosis, ITP therapy was administered. ITP in the present
case was most likely triggered by the babesia infection. The severity of ITP in this case was not proportional
to the severity of parasitemia. The neoantigen triggering the autoimmune response in babesiosis requires
further characterization.
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Introduction
Babesiosis is a common tick borne zoonosis with a diverse
spectrum of severity. Patients most often present with fevers,
headaches, severe myalgias and nausea. Severe babesiosis
can be a life threatening condition causing acute respiratory
distress syndrome, renal failure, cytopenias and disseminated
intravascular coagulation (DIC) (1,2). The parasite level and
the severity of the disease do not always correlate. Persistent
parasitemia has been described in both immunocompetent
patients with and without treatment and more frequently in
immunocompromised population (3). Common laboratory
findings include hemolytic anemia, thrombocytopenia and
elevated liver enzymes (1,2). However, babesia triggering
new onset severe immune thrombocytopenia (ITP) has not
been reported in the literature. Here we present a case of
a patient with babesiosis and new onset severe ITP despite
low parasitemia.
Case presentation
A septuagenarian woman with past medical history
of asthma was transferred to our institution from an
outside hospital for management of babesiosis and
thrombocytopenia. A week before admission, she developed
flu-like symptoms followed by progressive decrease in
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exercise tolerance and dyspnea on exertion. Diffuse rash on
both her legs prompted her to seek medical evaluation. She
also reported excessive bruises and ecchymosis following
blood draws. Review of systems was negative for fever,
chills, chest pain, weight changes, nausea, abdominal
pain or vomiting. Her last blood count obtained one year
earlier was normal. She denied any significant personal or
family history of bleeding/clotting disorders. In the outside
hospital babesia organisms were found in the peripheral
blood smear, with estimated load of 0.5%. Upon admission
to our hospital the parasite load was 0.3%. She was found
to have platelet count of 1,000/mcL, LDH 243 IU/L,
total bilirubin 1.1 mg/dL and haptoglobin 92 mg/dL. On
physical examination splenomegaly, diffuse petechial rash
and ecchymoses were present. Peripheral blood smear
revealed no evidence of thrombotic microangiopathy.
Platelets auto-antibody was reported as being strongly
positive. Ehrlichia and Lyme titers were negative.
Cytomegalovirus and Ebstein-Barr virus antibodies were
detected in IgG class, but not IgM. She also had negative
dengue and human immunodeficiency virus serology.
ADAMTS 13 activity was within normal limits. Abdominal
ultrasonography revealed hepatosplenomegaly. She was
initially given intravenous clindamycin and quinine, which
were later changed to oral atovaquone and azithromycin
to complete a course of antibiotic therapy for babesiosis.
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The patient received intravenous immunoglobulin (IVIG)
for babesiosis-associated ITP. Serial blood smears showed
clearance of parasitemia. Babesia microti DNA PCR was
not detected prior to discharge. The patient was discharged
with platelet count of 104,000/mcL with sustained trend
upwards. Following discharge the platelet count further
increased to 169,000/mcL within three days and to
309,000/mcL within 10 days.

It remains unclear whether in this case babesia infection
triggered the ITP. In the reported by us case, the patient was
a previously healthy individual. We conclude that ITP was
most likely triggered by the babesia infection. The severity
of ITP in this case did not correlate with parasitemia
which was only 0.3%. Multiple mechanisms of ITP have
been previously described in the literature (15-18). The
pathogenetic mechanisms of ITP associated with babesiosis
remain elusive and require further characterization.

Discussion
Babesia species are intra-erythrocytic parasites. Effective
cellular response and spleen play a major role in host
defense against babesiosis. Splenectomy and advancing age
related decline in cellular immunity are major risk factors
for severe babesiosis (2,4). Thrombocytopenia is a common
hematologic finding in tick borne diseases (5). Splenomegaly
with peripheral destruction of platelets, direct consumption
and injury to the platelets and marrow suppression are a
few mechanisms of thrombocytopenia described in the
literature. Dumler et al. studied bone marrow findings of a
few patients with human ehrlichiosis and reported findings
ranging from megakaryocytosis and myeloid hyperplasia
to pancellular hypoplasia (6). Non-immune mediated
platelet consumption and destruction leading to diffuse
intravascular coagulation and thrombotic thrombocytopenia
purpura have been described in tick borne illnesses like
ehrlichiosis, babesiosis and rocky mountain spotted fever.
Autoimmune antibodies were reported in babesiosis and
ehrlichiosis. Auerbach et al. described hemophagocytosis in
a case of severe babesiosis which cleared after appropriate
antibiotic therapy (7). Autoimmune phenomena have also
been found to be contributory factors for thrombocytopenia
in tick borne illnesses. Wong et al. used flow cytometry
to demonstrate presence of anti-platelet antibodies in
patients with human granulomatous ehrlichiosis (8,9).
However, in the review of the literature to date, we have
not found a report of babesiosis causing new onset ITP
in an otherwise healthy individual. Animal models have
previously demonstrated immune phenomena against
platelets in the setting of babesia infection. Lewis et al.
demonstrated the presence of anti-platelet antibodies in
the serum of dogs with babesiosis and ehrlichiosis (10,11).
Orinda et al. reported auto ITP caused by autoantibodies to
phosphatidyl-serine in cattle infected by babesia bovis (12).
ITP was also described in a patient with history of Hodgkin
lymphoma with splenectomy who presented with malaria
and was diagnosed with babesia divergens infection (13,14).
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Conclusions
Thrombocytopenia is a common feature of babesiosis.
ITP could be a probable cause and should be considered
in patients with new onset severe thrombocytopenia.
In addition to antibiotics for treatment of babesiosis,
ITP treatment should be initiated in severe cases. The
neoantigen triggering the autoimmune response in
babesiosis requires further characterization.
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